{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:24:14Z","timestamp":1790036654264,"version":"4.0.1"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:00:00Z","timestamp":1743897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Injection therapy has emerged as a possible treatment for the acute phase of Peyronie\u2019s disease (PD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To systematically review the current evidence on the efficacy and safety of injection therapy for patients in the acute phase of PD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A comprehensive bibliographic search on the MEDLINE, Scopus, and Web of Science Core Collection databases was conducted in June 2024. Articles were selected if they included patients with PD in acute phase (P) undergoing injection therapy (I) with or without comparison with other treatments (C), evaluating its efficacy or safety (O). Prospective and retrospective original studies were included (S). Articles were assessed for risk of bias using Cochrane risk-of-bias tool for randomized trials version 2, risk of bias in non-randomized studies-of interventions, and Joanna Briggs Institute critical appraisal tool. Data were synthesized narratively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>Primary outcomes were penile curvature, penile pain, and adverse events.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 20 studies (1291 patients) were included, with 4 (20%) being randomized controlled trials. The mean\/median duration of PD symptoms ranged from 2.0 to 18.6\u00a0months across the papers. The injectable agents tested included calcium channel blockers, hyaluronic acid, Collagenase Clostridium histolyticum, interferon, and corticosteroids. In most studies, improvements in penile curvature and pain were observed, with variable magnitude and in a varying percentage of patients. Adverse events were mostly mild and localized, including bruising, swelling, and ecchymosis. No severe complications were reported in any of the studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>Limited evidence support the feasibility of injection therapy for the acute phase of PD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths and Limitations<\/jats:title>\n                  <jats:p>The first systematic review on injection therapy for acute PD. Low-to-intermediate quality and heterogeneous methodology of primary studies, impossibility of reliable quantitative data synthesis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Injection therapy for the acute phase of PD demonstrates variable efficacy depending on the agent used and a relatively favorable safety profile; however, the overall quality of evidence remains low and is characterized by significant methodological limitations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdaf044","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T12:09:49Z","timestamp":1743682189000},"page":"799-812","source":"Crossref","is-referenced-by-count":4,"title":["Injection therapy in the acute phase of Peyronie\u2019s disease: a systematic review of current evidence"],"prefix":"10.1093","volume":"22","author":[{"given":"Celeste","family":"Manfredi","sequence":"first","affiliation":[{"name":"Unit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania \u201cLuigi Vanvitelli\u201d , 80131 Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Ivan","family":"Russo","sequence":"additional","affiliation":[{"name":"Urology Section, Department of Surgery, University of Catania , 95124 Catania ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2347-9504","authenticated-orcid":false,"given":"Paolo","family":"Capogrosso","sequence":"additional","affiliation":[{"name":"Department of Urology and Andrology, Ospedale di Circolo and Macchi Foundation , 21100 Varese ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Falcone","sequence":"additional","affiliation":[{"name":"Department of Urology, A.O.U. Citt\u00e0 della Salute e della Scienza , 10126 Turin ,","place":["Italy"]},{"name":"Department of Urology, Biruni University , 34015 Istanbul ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1938-8004","authenticated-orcid":false,"given":"Ioannis","family":"Sokolakis","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, Aristotle University of Thessaloniki , 54124 Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Schoentgen","sequence":"additional","affiliation":[{"name":"Urology Department, University Hospital Center Bichat Claude Bernard , 75018 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Morozov","sequence":"additional","affiliation":[{"name":"Institute for Urology and Reproductive Health, Sechenov University , 119991 Moscow ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazhar","family":"Orta\u00e7","sequence":"additional","affiliation":[{"name":"Department of Urology, Istanbul University , 34452 Istanbul ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afonso","family":"Morgado","sequence":"additional","affiliation":[{"name":"Department of Urology, Centro Hospitalar Universit\u00e1rio S\u00e3o Jo\u00e3o , 4200 319 Porto ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1951-404X","authenticated-orcid":false,"given":"Marco","family":"Capece","sequence":"additional","affiliation":[{"name":"Unit of Urology, Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II , 80131 Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Arcaniolo","sequence":"additional","affiliation":[{"name":"Unit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania \u201cLuigi Vanvitelli\u201d , 80131 Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Romero-Otero","sequence":"additional","affiliation":[{"name":"Department of Urology, HM Hospitales , 28050 Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7045-7725","authenticated-orcid":false,"given":"Riccardo","family":"Autorino","sequence":"additional","affiliation":[{"name":"Department of Urology, Rush University Medical Center , 60612 Chicago, IL ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"De Sio","sequence":"additional","affiliation":[{"name":"Unit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania \u201cLuigi Vanvitelli\u201d , 80131 Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Urology, Rush University Medical Center , 60612 Chicago, IL ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"YAU Working Group Sexual and Reproductive Health","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,6]]},"reference":[{"issue":"4","key":"2025051303322229700_ref1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ucl.2007.08.017","article-title":"Peyronie\u2019s disease","volume":"34","author":"Taylor","year":"2007","journal-title":"Urol Clin N Am"},{"issue":"7","key":"2025051303322229700_ref2","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/j.1743-6109.2007.00692.x","article-title":"A brief historical survey of \u201cPeyronie\u2019s disease\u201d","volume":"5","author":"Musitelli","year":"2008","journal-title":"J Sex Med"},{"issue":"2","key":"2025051303322229700_ref3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.sxmr.2019.06.004","article-title":"The etiology of Peyronie\u2019s disease: pathogenesis and genetic contributions","volume":"8","author":"Sharma","year":"2020","journal-title":"Sex Med Rev"},{"issue":"6","key":"2025051303322229700_ref4","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39746-X","article-title":"The natural history of Peyronie\u2019s disease","volume":"144","author":"Gelbard","year":"1990","journal-title":"J Urol"},{"issue":"3","key":"2025051303322229700_ref5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.5534\/wjmh.200065","article-title":"The natural history of Peyronie\u2019s disease","volume":"39","author":"Di Maida","year":"2021","journal-title":"World J Mens Health"},{"key":"2025051303322229700_ref6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/RRU.S65620","article-title":"A review of the epidemiology and treatment of Peyronie\u2019s disease","volume":"8","author":"Walsh","year":"2016","journal-title":"Res Rep Urol"},{"issue":"6","key":"2025051303322229700_ref7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/iju.14230","article-title":"Peyronie\u2019s disease: contemporary evaluation and management","volume":"27","author":"Ziegelmann","year":"2020","journal-title":"Int J Urol"},{"issue":"2","key":"2025051303322229700_ref8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.sxmr.2018.09.007","article-title":"Review of management options for active-phase Peyronie\u2019s disease","volume":"7","author":"Brimley","year":"2019","journal-title":"Sex Med Rev"},{"issue":"3","key":"2025051303322229700_ref9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.21037\/tau.2016.03.15","article-title":"Injectable therapy for Peyronie\u2019s disease","volume":"5","author":"Chong","year":"2016","journal-title":"Transl Androl Urol"},{"key":"2025051303322229700_ref10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"2025051303322229700_ref11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching PubMed for clinical questions","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med Inform Decis Mak"},{"issue":"4","key":"2025051303322229700_ref12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.sxmr.2022.08.001","article-title":"A consistent lack of consistency in defining the acute and chronic phases of Peyronie\u2019s disease: a review of the contemporary literature","volume":"10","author":"Piraino","year":"2022","journal-title":"Sex Med Rev"},{"issue":"2","key":"2025051303322229700_ref13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41443-022-00651-8","article-title":"Daily low-dose tadalafil may reduce the penile curvature progression rate in patients with acute Peyronie\u2019s disease: a retrospective comparative analysis","volume":"36","author":"Spirito","year":"2024","journal-title":"Int J Impot Res"},{"key":"2025051303322229700_ref14","volume-title":"The 2011 Oxford CEBM Levels of Evidence","author":"Howick"},{"issue":"366","key":"2025051303322229700_ref15","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"28","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2025051303322229700_ref16","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"10","key":"2025051303322229700_ref17","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.11124\/JBISRIR-D-19-00099","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"10","key":"2025051303322229700_ref18","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s11255-015-1074-1","article-title":"Intralesional hyaluronic acid: an innovative treatment for Peyronie\u2019s disease","volume":"47","author":"Gennaro","year":"2015","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"2025051303322229700_ref19","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/j.esxm.2016.01.002","article-title":"Intralesional injection of hyaluronic acid in patients affected with Peyronie\u2019s disease: preliminary results from a prospective, multicenter, pilot study","volume":"4","author":"Zucchi","year":"2016","journal-title":"Sex Med"},{"issue":"4","key":"2025051303322229700_ref20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/andr.12368","article-title":"Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie\u2019s disease: preliminary results from a prospective, double-blinded, randomized study","volume":"5","author":"Favilla","year":"2017","journal-title":"Andrology"},{"issue":"3","key":"2025051303322229700_ref21","doi-asserted-by":"publisher","first-page":"526","DOI":"10.5534\/WJMH.200048","article-title":"Oral administration and intralesional injection of hyaluronic acid versus intralesional injection alone in peyronie\u2019s disease: results from a phase III study","volume":"39","author":"Cai","year":"2020","journal-title":"World J Mens Health"},{"issue":"2","key":"2025051303322229700_ref22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.5534\/wjmh.190108","article-title":"Comparison of intralesional hyaluronic acid vs. verapamil for the treatment of acute phase Peyronie\u2019s disease: a prospective, open-label non-randomized clinical study","volume":"39","author":"Cocci","year":"2020","journal-title":"World J Mens Health"},{"issue":"7","key":"2025051303322229700_ref23","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1046\/j.1464-410X.2001.02139.x","article-title":"Treatment of Peyronie\u2019s disease with local interferon-\u03b1 2b","volume":"87","author":"Brake","year":"2001","journal-title":"BJU Int"},{"issue":"1","key":"2025051303322229700_ref24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","article-title":"Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon \u03b1-2b for minimally invasive treatment for Peyronie\u2019s disease","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J Urol"},{"issue":"2","key":"2025051303322229700_ref25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4103\/UA.UA_65_17","article-title":"Prospective study to evaluate the clinical outcome of intralesional interferon-2b in the management of Peyronie\u2019s disease","volume":"10","author":"Sokhal","year":"2018","journal-title":"Urol Ann"},{"issue":"1","key":"2025051303322229700_ref26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0022-5347(17)62993-8","article-title":"Steroid injection therapy for Peyronie\u2019s disease: a 10-year summary and review of 38 cases","volume":"97","author":"Desanctis","year":"1967","journal-title":"J Urol"},{"issue":"3","key":"2025051303322229700_ref27","doi-asserted-by":"publisher","first-page":"e13754","DOI":"10.1111\/ijcp.13754","article-title":"Intralesional low-dose methylprednisolone for the treatment of active phase Peyronie\u2019s disease: a single-centre, preliminary prospective non-randomised study","volume":"75","author":"Ure","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"6","key":"2025051303322229700_ref28","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/S0022-5347(17)35291-6","article-title":"Intralesional verapamil injection for the treatment of Peyronie\u2019s disease","volume":"151","author":"Levine","year":"1994","journal-title":"J Urol"},{"issue":"4","key":"2025051303322229700_ref29","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/S0022-5347(01)64224-1","article-title":"Treatment of Peyronie\u2019s disease with intralesional verapamil injection","volume":"158","author":"Levine","year":"1997","journal-title":"J Urol"},{"issue":"2","key":"2025051303322229700_ref30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/00005392-200208000-00045","author":"Levine","year":"2002","journal-title":"J Urol"},{"issue":"11","key":"2025051303322229700_ref31","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1111\/j.1743-6109.2010.01924.x","article-title":"Nicardipine vs. saline injection as treatment for peyronie\u2019s disease: a prospective, randomized, single-blind trial","volume":"7","author":"Soh","year":"2010","journal-title":"J Sex Med"},{"issue":"7","key":"2025051303322229700_ref32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5539\/gjhs.v6n7p23","article-title":"Evaluation of verapamil efficacy in Peyronie\u2019s disease comparing with pentoxifylline","volume":"6","author":"Alizadeh","year":"2014","journal-title":"Global J Health Sci"},{"key":"2025051303322229700_ref33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.urology.2016.04.049","article-title":"Peyronie\u2019s disease and injectable collagenase Clostridium histolyticum: safety, efficacy, and improvements in subjective symptoms","volume":"94","author":"Yang","year":"2016","journal-title":"Urology"},{"issue":"10","key":"2025051303322229700_ref34","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.jsxm.2017.08.008","article-title":"Safety and efficacy of collagenase Clostridium histolyticum in the treatment of acute-phase Peyronie\u2019s disease","volume":"14","author":"Nguyen","year":"2017","journal-title":"J Sex Med"},{"key":"2025051303322229700_ref35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.urology.2020.07.048","article-title":"Safety and efficacy of collagenase Clostridium histolyticum in the treatment of acute phase Peyronie\u2019s disease: a multi-institutional analysis","volume":"145","author":"Nguyen","year":"2020","journal-title":"Urology"},{"issue":"6","key":"2025051303322229700_ref36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s40261-020-00916-4","article-title":"Efficacy of collagenase Clostridium histolyticum (Xiapex\u00ae) in patients with the acute phase of Peyronie\u2019s disease","volume":"40","author":"Cocci","year":"2020","journal-title":"Clin Drug Investig"},{"issue":"8","key":"2025051303322229700_ref37","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.21037\/tau-22-188","article-title":"Intralesional collagenase Clostridium histolyticum for acute phase Peyronie\u2019s disease: a single-center, retrospective cohort study","volume":"11","author":"Hu","year":"2022","journal-title":"Transl Androl Urol"},{"issue":"3","key":"2025051303322229700_ref38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4103\/aja.aja_74_20","article-title":"Role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in Peyronie\u2019s disease","volume":"23","author":"Rojo","year":"2021","journal-title":"Asian J Androl"},{"key":"2025051303322229700_ref39","author":"Salonia"},{"issue":"11","key":"2025051303322229700_ref40","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/diagnostics14111125","article-title":"Clinical presentation of Peyronie\u2019s disease: a retrospective study of 564 cases","volume":"14","author":"Paulis","year":"2024","journal-title":"Diagnostics"},{"issue":"3","key":"2025051303322229700_ref41","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/JU.0000000000004072","article-title":"Creation of a novel classification system (PTNM) for Peyronie\u2019s disease and penile curvature using evidence-based criteria","volume":"212","author":"Trost","year":"2024","journal-title":"J Urol"},{"key":"2025051303322229700_ref42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/RRU.S278796","article-title":"Peyronie\u2019s disease: an outcomes-based guide to non-surgical and novel treatment modalities","volume":"15","author":"Reddy","year":"2023","journal-title":"Res Rep Urol"},{"issue":"1","key":"2025051303322229700_ref43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/bju.12346","article-title":"Deformity stabilization and improvement in men with untreated Peyronie\u2019s disease","volume":"113","author":"Berookhim","year":"2014","journal-title":"BJU Int"},{"issue":"1","key":"2025051303322229700_ref44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12610-022-00164-w","article-title":"Use of penile shear wave elastosonography for the diagnosis of Peyronie\u2019s disease: a prospective case\u2013control study","volume":"32","author":"Trama","year":"2022","journal-title":"Basic Clin Androl"},{"issue":"2","key":"2025051303322229700_ref45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/0092623X.2014.985351","article-title":"The impact of Peyronie\u2019s disease on the patient: gaps in our current understanding","volume":"42","author":"Goldstein","year":"2016","journal-title":"J Sex Marital Ther"},{"issue":"5","key":"2025051303322229700_ref46","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jsxm.2021.03.007","article-title":"Penile implant surgery satisfaction assessment","volume":"18","author":"Manfredi","year":"2021","journal-title":"J Sex Med"},{"issue":"3","key":"2025051303322229700_ref47","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1590\/s1677-5538.ibju.2017.0418","article-title":"Objective measurements of the penile angulation are significantly different than self-estimated magnitude among patients with penile curvature","volume":"44","author":"Liguori","year":"2018","journal-title":"Int Braz J Urol"},{"issue":"2","key":"2025051303322229700_ref48","doi-asserted-by":"publisher","DOI":"10.1111\/and.13480","article-title":"Is topical alprostadil an usable and reliable alternative to intracavernous injection for penile dynamic duplex ultrasonography?","volume":"52","author":"Arcaniolo","year":"2020","journal-title":"Andrologia"},{"issue":"1","key":"2025051303322229700_ref49","doi-asserted-by":"publisher","first-page":"120","DOI":"10.21037\/tau.2017.01.03","article-title":"Complications and other concerns with intralesional injection therapy with collagenase Clostridium histolyticum for Peyronie\u2019s disease","volume":"6","author":"Levine","year":"2017","journal-title":"Transl Androl Urol"},{"issue":"3","key":"2025051303322229700_ref50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/bju.15145","article-title":"Non-invasive and surgical penile enhancement interventions for aesthetic or therapeutic purposes: a systematic review","volume":"127","author":"Romero-Otero","year":"2021","journal-title":"BJU Int"},{"key":"2025051303322229700_ref51","doi-asserted-by":"publisher","first-page":"m2917","DOI":"10.1136\/bmj.m2917","article-title":"Prospective validation of classification of intraoperative adverse events (ClassIntra): international, multicentre cohort study","volume":"370","author":"Dell-Kuster","journal-title":"BMJ"},{"issue":"2","key":"2025051303322229700_ref52","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jsxm.2018.12.011","article-title":"Comparative effectiveness of intralesional therapy for Peyronie\u2019s disease in controlled clinical studies: a systematic review and network meta-analysis","volume":"16","author":"Russo","year":"2019","journal-title":"J Sex Med"},{"issue":"3","key":"2025051303322229700_ref53","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4103\/aja202371","article-title":"Intraplaque injections of hyaluronic acid for the treatment of stable-phase Peyronie\u2019s disease: a retrospective single-center experience","volume":"26","author":"Cilio","year":"2024","journal-title":"Asian J Androl"},{"issue":"12","key":"2025051303322229700_ref54","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1111\/jsm.12334","article-title":"Peyronie\u2019s disease plaque calcification\u2014prevalence, time to identification, and development of a new grading classification","volume":"10","author":"Levine","year":"2013","journal-title":"J Sex Med"},{"issue":"1","key":"2025051303322229700_ref55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.euf.2022.09.019","article-title":"Collagenase Clostridium histolyticum treatment improves degree of curvature in Peyronie\u2019s disease with calcified plaques","volume":"9","author":"Masterson","year":"2023","journal-title":"Eur Urol Focus"},{"issue":"3","key":"2025051303322229700_ref56","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.sxmr.2020.05.003","article-title":"Intralesional injection therapy and atypical Peyronie\u2019s disease: a systematic review","volume":"9","author":"Choi","year":"2021","journal-title":"Sex Med Rev"},{"issue":"10","key":"2025051303322229700_ref57","doi-asserted-by":"publisher","DOI":"10.1111\/and.13740","article-title":"Efficacy and safety of dorsal penile nerve block before collagenase of Clostridium histolyticum injections in Peyronie\u2019s disease patients: results from a prospective pilot study","volume":"52","author":"Garc\u00eda, Rojo","year":"2020","journal-title":"Andrologia"},{"issue":"3","key":"2025051303322229700_ref58","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.sxmr.2022.01.001","article-title":"Penile modeling in Peyronie\u2019s disease: a systematic review of the literature","volume":"10","author":"Krishnappa","year":"2022","journal-title":"Sex Med Rev"},{"issue":"4","key":"2025051303322229700_ref59","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.acuro.2018.08.005","article-title":"Diez a\u00f1os de experiencia con el tratamiento multimodal de la fase aguda de la enfermedad de Peyronie: reporte m\u00e9dico de la vida real","volume":"43","author":"Gallo","year":"2019","journal-title":"Actas Urol Esp"},{"issue":"7","key":"2025051303322229700_ref60","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/andr.13240","article-title":"Impact of extracorporeal shockwave therapy for erectile dysfunction and Peyronie\u2019s disease on reproductive and hormonal testicular function","volume":"10","author":"Manfredi","year":"2022","journal-title":"Andrology"},{"issue":"2","key":"2025051303322229700_ref61","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41443-023-00673-w","article-title":"Long-term outcomes of extracorporeal shock wave therapy for acute Peyronie\u2019s disease: a 10-year retrospective analysis","volume":"36","author":"Spirito","year":"2024","journal-title":"Int J Impot Res"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/5\/799\/62874769\/qdaf044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/5\/799\/62874769\/qdaf044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:32:28Z","timestamp":1747121548000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/22\/5\/799\/8106821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,6]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,6]]},"published-print":{"date-parts":[[2025,5,10]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdaf044","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"value":"1743-6095","type":"print"},{"value":"1743-6109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,4,6]]}}}